Breaking down translation barriers: Investigator's perspective

Nathan P Staff, Bethany Kinseth Runge, Anthony John Windebank

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

From our perspective as biomedical scientists, we analyze new initiatives from U.S. federal regulatory and funding agencies aimed at accelerating the process of clinical translation.

Original languageEnglish (US)
Article number252cm7
JournalScience Translational Medicine
Volume6
Issue number252
DOIs
StatePublished - Sep 3 2014

Fingerprint

Research Personnel

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Breaking down translation barriers : Investigator's perspective. / Staff, Nathan P; Runge, Bethany Kinseth; Windebank, Anthony John.

In: Science Translational Medicine, Vol. 6, No. 252, 252cm7, 03.09.2014.

Research output: Contribution to journalArticle

@article{b66a7c91307445ae849801c53966752d,
title = "Breaking down translation barriers: Investigator's perspective",
abstract = "From our perspective as biomedical scientists, we analyze new initiatives from U.S. federal regulatory and funding agencies aimed at accelerating the process of clinical translation.",
author = "Staff, {Nathan P} and Runge, {Bethany Kinseth} and Windebank, {Anthony John}",
year = "2014",
month = "9",
day = "3",
doi = "10.1126/scitranslmed.3008252",
language = "English (US)",
volume = "6",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "252",

}

TY - JOUR

T1 - Breaking down translation barriers

T2 - Investigator's perspective

AU - Staff, Nathan P

AU - Runge, Bethany Kinseth

AU - Windebank, Anthony John

PY - 2014/9/3

Y1 - 2014/9/3

N2 - From our perspective as biomedical scientists, we analyze new initiatives from U.S. federal regulatory and funding agencies aimed at accelerating the process of clinical translation.

AB - From our perspective as biomedical scientists, we analyze new initiatives from U.S. federal regulatory and funding agencies aimed at accelerating the process of clinical translation.

UR - http://www.scopus.com/inward/record.url?scp=84907290528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907290528&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3008252

DO - 10.1126/scitranslmed.3008252

M3 - Article

C2 - 25186172

AN - SCOPUS:84907290528

VL - 6

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 252

M1 - 252cm7

ER -